McKesson Corporation has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC (FCS). Announced by McKesson on [insert date here], the transaction gives McKesson a 70% controlling interest in Core Ventures for approximately $2.49 billion, while FCS physicians retain a 30% stake. This acquisition aims to enhance community-based oncology care, accelerate clinical development, and expand access to quality cancer care in local communities. FCS, with over 250 physicians and 280 advanced practice providers across nearly 100 locations in Florida, remains independently owned and joins McKesson's The US Oncology Network.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.